丙戊酸钠与迟发性运动障碍

Br J Psychiatry. 1978 Jul;133:82. doi: 10.1192/bjp.133.1.82.

Twenty-five schizophrenic patients with tardive dyskinesia was given 600 mgs sodium valproate daily with their neuroleptic medication. After one month there was no change in their signs, as judged by a panel of nine viewing films of them taken before and at the end of this treatment.

25名患有迟发性运动障碍的精神分裂症患者在服用抗精神病药物的同时，每天服用600毫克丙戊酸钠。一个月后，由九名专家组成的小组通过观看他们治疗前和治疗结束时拍摄的影片判断，他们的症状没有变化。